Assessment of low plasma concentrations of apixaban in the periprocedural setting.
Lessire S, Dincq AS, Siriez R, Pochet L, Sennesael AL, Vornicu O, Hardy M, Deceuninck O, Douxfils J, Mullier F.
Int J Lab Hematol. 2020 Aug;42(4):394-402. doi: 10.1111/ijlh.13202. Epub 2020 Apr 16.
Neutralisation of the anti-coagulant effects of heparin by histones in blood plasma and purified systems.
Longstaff C, Hogwood J, Gray E, Komorowicz E, Varjú I, Varga Z, Kolev K.
Thromb Haemost. 2016 Mar;115(3):591-9. doi: 10.1160/TH15-03-0214. Epub 2015 Dec 3.
Complexation of a poly-L-arginine with low molecular weight heparin enhances pulmonary absorption of the drug.
Rawat A, Yang T, Hussain A, Ahsan F.
Pharm Res. 2008 Apr;25(4):936-48. doi: 10.1007/s11095-007-9442-x. Epub 2007 Oct 23.
A prophylactic subcutaneous dose of the anticoagulant tinzaparin does not influence qPCR-based assessment of circulating levels of miRNA in humans.
Nilsson A, Nerhall AM, Vechetti I, Fornander L, Wiklund S, Alkner B, Schilcher J, von Walden F.
PLoS One. 2022 Nov 3;17(11):e0277008. doi: 10.1371/journal.pone.0277008. eCollection 2022.
Measurement of fluorescent-labeled LMM-heparin in biological fluids using protamine-linked microbeads.
Malsch R, Melui D, Piazolo L, Harenberg J, Heene DL.
Semin Thromb Hemost. 1997;23(1):23-30. doi: 10.1055/s-2007-996066.
Evaluation of a Heparin-Calibrated Antifactor Xa Assay for Measuring the Anticoagulant Effect of Oral Direct Xa Inhibitors.
Beyer J, Trujillo T, Fisher S, Ko A, Lind SE, Kiser TH.
Clin Appl Thromb Hemost. 2016 Jul;22(5):423-8. doi: 10.1177/1076029616629759. Epub 2016 Feb 2.
Simvastatin ameliorates deep vein thrombosis in rabbits by regulating the fibrinolytic system.
Feng Y, Zhang F, Niu L, Zhang M.
Blood Coagul Fibrinolysis. 2016 Jul;27(5):531-41. doi: 10.1097/MBC.0000000000000567.
Quantitative determination of PEG-hirudin in human plasma using a competitive enzyme-linked immunosorbent assay.
Song XH, Huhle G, Wang LC, Harenberg J.
Thromb Res. 2000 Jul 15;99(2):195-202. doi: 10.1016/s0049-3848(00)00246-2.
Identification of lipoprotein lipase immunoreactive protein in pre- and postheparin plasma from normal subjects and patients with type I hyperlipoproteinemia.
Kern PA, Martin RA, Carty J, Goldberg IJ, Ong JM.
J Lipid Res. 1990 Jan;31(1):17-26.
Relationship between ex vivo anti-proteinase (factor Xa and thrombin) assays and in vivo anticoagulant effect of very low molecular weight heparin, CY222.
Tew CJ, Lane DA, Thompson E, Ireland H, Curtis JR.
Br J Haematol. 1988 Nov;70(3):335-40. doi: 10.1111/j.1365-2141.1988.tb02491.x.
